Darrell K Royal Texas Alzheimer's Initiative

In October 2012, Council members unanimously voted to rename all funded Alzheimer’s disease efforts under their purview to the “Darrell K Royal Texas Alzheimer's Initiative”.  This initiative is committed to fostering excellence in research through the legislatively mandated Texas Alzheimer’s Research and Care Consortium; addressing the burden of Alzheimer’s disease in Texas through statewide strategic planning; promoting collaborative research projects among Texas Alzheimer’s researchers, and coordinating/supporting other state funded activities as they relate to Alzheimer’s disease. 

The Texas Alzheimer's Research and Care Consortium (TARCC) is a legislatively mandated collaboration between six of the state’s leading medical research institutions to improve early diagnosis, treatment, and prevention of Alzheimer’s disease.  Through their work, the TARCC has established a large state research cohort (the Harris Alzheimer's Research Study), and have enrolled more than 2000 participants since its inception in 2002.  TARCC researchers contribute data into a shared databank, housing standardized clinical, neuropsychiatric, genetic and blood biomarker data on Alzheimer's patients, individuals diagnosed with mild cognitive impairment and healthy control subjects who are seen at each of the TARCC member sites. Samples and data from TARCC participants are collected annually at follow up visits. The longitudinal nature of the TARCC study is a key strength, allowing for analysis of disease progression.

Statewide strategic planning is accomplished through the implementation of the 2010-2015 Texas State Plan on Alzheimer's Disease.  This plan was developed in direct response to the growing prevalence of Alzheimer's disease by the Council, the Alzheimer’s Disease Program at the Department of State Health Services, and more than 150 committed volunteers from across the state.  Integral to the success of the plan are high levels of commitment and collaboration by all stakeholders involved. Ongoing coordination, information and resource sharing, partnership development, and capacity building are essential for Texas in creating the momentum to sustain a statewide resourced system to promote and advance the recommendations of this plan.

The Darrell K Royal Research Fund for Alzheimer’s Disease is a granting foundation established to serve as a nexus for Alzheimer’s disease research in Texas through the funding of clinical and basic collaborative research projects.  The DKR fund represents the commitment to excellence in research and care for Texans to attempt to cure Alzheimer's disease in our lifetimes, to expand research into mild cognitive impairment, and to expand the paradigms of care and access for Texans enabling exposure to preventative and treatment strategies aimed at combatting the epidemic of Alzheimer’s.  Research projects must include a least one Texas based applicant, include a clinical component with at least one Texas based partner/applicant, and display novel innovations in the proposed methods of collaboration. 

 

Last updated April 25, 2019